Table 2.
The mean and standard deviation of variables in the study before and after treatment in the group treated with metformin and Sitagliptin (group 1)
| Variable | MEAN ± SD | P value | |
|---|---|---|---|
| Before treatment | After treatment | ||
| FBS (mg/dl) | 171.09 ± 46.41 | 152.60 ± 42.33 | <0.001 |
| BS2hpp (mg/dl) | 276.80 ± 62.08 | 228.29 ± 63.18 | <0.001 |
| HbA1c (%) | 8.74 ± 0.60 | 7.74 ± 0.90 | <0.001 |
| BUN (mg/dl) | 10.30 ± 1.97 | 10.18 ± 1.99 | 0.55 |
| Creatinin (mg/dl) | 0.94 ± 0.169 | 0.958 ± 0.15 | 0.48 |
| AST (U/L) | 40.98 ± 37.52 | 37.99 ± 23.55 | 0.78 |
| ALT (U/L) | 40.89 ± 28.19 | 38.14 ± 16.83 | 0.63 |
| TG (mg/dl) | 168.38 ± 80.76 | 133.98 ± 55.38 | <0.001 |
| Chol (mg/dl) | 177.00 ± 46.51 | 153.31 ± 34.91 | <0.001 |
| HDL (mg/dl) | 43.18 ± 8.38 | 46.35 ± 12.19 | 0.006 |
| Weight (kg) | 74.29 ± 13.62 | 73.2 ± 13.13 | <0.001 |
| SBP (mmHg) | 129.00 ± 18.18 | 125.50 ± 13.20 | 0.025 |
| DBP (mmHg) | 80.00 ± 9.27 | 77.88 ± 7.41 | 0.012 |